Cargando…
Structure, mechanism and crystallographic fragment screening of the SARS-CoV-2 NSP13 helicase
There is currently a lack of effective drugs to treat people infected with SARS-CoV-2, the cause of the global COVID-19 pandemic. The SARS-CoV-2 Non-structural protein 13 (NSP13) has been identified as a target for anti-virals due to its high sequence conservation and essential role in viral replica...
Autores principales: | Newman, Joseph A., Douangamath, Alice, Yadzani, Setayesh, Yosaatmadja, Yuliana, Aimon, Antony, Brandão-Neto, José, Dunnett, Louise, Gorrie-stone, Tyler, Skyner, Rachael, Fearon, Daren, Schapira, Matthieu, von Delft, Frank, Gileadi, Opher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358061/ https://www.ncbi.nlm.nih.gov/pubmed/34381037 http://dx.doi.org/10.1038/s41467-021-25166-6 |
Ejemplares similares
-
Allosteric regulation and crystallographic fragment screening of SARS-CoV-2 NSP15 endoribonuclease
por: Godoy, Andre Schutzer, et al.
Publicado: (2023) -
Fragment Binding to the Nsp3 Macrodomain of SARS-CoV-2 Identified Through Crystallographic Screening and Computational Docking
por: Schuller, Marion, et al.
Publicado: (2020) -
Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking
por: Schuller, Marion, et al.
Publicado: (2021) -
Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease
por: Douangamath, Alice, et al.
Publicado: (2020) -
Characterization of the SARS-CoV-2 ExoN (nsp14(ExoN)–nsp10) complex: implications for its role in viral genome stability and inhibitor identification
por: Baddock, Hannah T, et al.
Publicado: (2022)